The science behind Simtriyo, the first ADHD medication to target three major neurotransmitters
A new medicine for attention-deficit hyperactivity disorder (ADHD) has just entered the treatment toolbox: centanafadine, a once-a-day tablet sold under the brand name Simtriyo. It has been approved in the…